Christopher Guiffre

Christopher D.
T.
Guiffre was the founder of Mercator Therapeutics, Inc. (2009) and served as President & Chief Executive Officer.
Current jobs include Chief Executive Officer at Pear Therapeutics, Inc. (2023), Member of the Massachusetts Bar Association, Chief Financial & Operating Officer at Pear Therapeutics (US), Inc. (2017), and President & Chief Operating Officer at Auron Therapeutics, Inc. (2023).
Former jobs include President & Chief Executive Officer at Alvos Therapeutics, Inc., Chief Executive Officer at Daré Bioscience, Inc. (2015-2017), VP, General Counsel & Director-Legal Affairs at Renaissance Worldwide, Inc. (1997-2001), Secretary, Senior Vice President & General Counsel at Cubist Pharmaceuticals LLC (2001-2008), Associate at BMC Partners LLP, Associate at Morgan, Lewis & Bockius LLP, Chief Business Officer at Hydra Biosciences, Inc., and Chief Operating Officer & Senior Vice President at Cerulean Pharma, Inc. (2014-2015).
Education includes an undergraduate degree from Babson College, a graduate degree from Boston College Law School, and an MBA from Wallace E Carroll School of Management.